vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: VTVT) | Delayed: 27.16 -0.61 (2.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.77 | 52 Week High | $7.70 | |||
| Open | $27.79 | 52 Week Low | $4.69 | |||
| Day High | $28.05 | P/E | N/A | |||
| Day Low | $27.02 | EPS | $0.00 | |||
| Volume | 10,767 | |||||
